Taryn Vos - Psyence Biomedical General Counsel
| PBMWW Stock | 0.01 0.0006 7.50% |
Executive
Taryn Vos is General Counsel of Psyence Biomedical Ltd
| Phone | 416-346-7764 |
| Web | https://www.psyencebiomed.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ravindra Simhambhatla | Avis Budget Group | 55 | |
| Angela Kervin | Vestis | 49 | |
| Cathleen DeGenova | Avis Budget Group | 62 | |
| Johann Rawlinson | Hertz Global Holdings | N/A | |
| Peter Rego | Vestis | N/A | |
| Timothy LangleyHawthorne | Hertz Global Holdings | 55 | |
| Laurence Respino | U Haul Holding | 63 | |
| April Dovholuk | Centessa Pharmaceuticals PLC | N/A | |
| Nachiappan Chidambaram | Lipocine | 55 | |
| Kristine Campbell | U Haul Holding | 48 | |
| Maria Bell | U Haul Holding | 53 | |
| Wayne Davis | Hertz Global Holdings | N/A | |
| Brian Choi | Avis Budget Group | 41 | |
| Patrick MD | Centessa Pharmaceuticals PLC | N/A | |
| Lauren Fritts | Hertz Global Holdings | 41 | |
| Laura Smith | Hertz Global Holdings | 45 | |
| Darren Arrington | Hertz Global Holdings | 47 | |
| Eric Leef | Hertz Global Holdings | 50 | |
| Henry Kuykendall | Hertz Global Holdings | N/A | |
| Jennifer Settles | U Haul Holding | N/A | |
| Ellie MD | Centessa Pharmaceuticals PLC | N/A | |
Psyence Biomedical Leadership Team
Elected by the shareholders, the Psyence Biomedical's board of directors comprises two types of representatives: Psyence Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Psyence. The board's role is to monitor Psyence Biomedical's management team and ensure that shareholders' interests are well served. Psyence Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Psyence Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taryn Vos, General Counsel | ||
| Jody Aufrichtig, Executive CoFounder | ||
| Neil MD, CEO Director | ||
| Tony Budden, Chief Officer | ||
| MaryElizabeth Gifford, Executive Impact | ||
| Warwick CordenLloyd, Chief Officer |
Psyence Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Psyence Biomedical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.